期刊文献+

盐酸依福地平共研磨物的制备及其溶出特性的考察 被引量:2

The preparation of efonidipine hydrochloride co-milling powder and investigate the dissolution: the influence of excipients
下载PDF
导出
摘要 目的通过行星式球磨法制备盐酸依福地平共研磨物以提高盐酸依福地平的溶出度。方法将盐酸依福地平与不同辅料进行共研磨,对不同的研磨时间、辅料的用量、辅料的形状及共研磨物粉体学性质等进行考察,使用了Peppas公式验证共研磨物的溶出机理,并用川北方程验证辅料流动性对共研磨物溶出的影响,从而筛选最优处方。结果 MCC PH101、MCC KG802、CL-CMC-Na与难溶性药物盐酸依福地平以质量比3∶1的比例共研磨后,能很好的改善其体外溶出度。结论棒状或纤维状辅料与盐酸依福地平可以产生"网络状"结构的共研磨物,既有效的防止了微粉化后药物自身的聚集,也改善了其溶出机制,大幅度提高了盐酸依福地平的溶出度。 Objective To improve the solubility of efonidipine hydrochloride using a planetary ball-milling technique. Methods Efonidipine hychloride was co-milled with different excipients, and the influence of different co-milling time on the dissolution rate, different content of excipients, the characteristic of excipients, powder properties of co-millings were studied. Peppas equation was used to explain the mechanism of dissolution, and Kawakita equation was applied to investigate the influence of flowability on dissolution. The optimized formulation was obtained. Results Efonidipine hydrochloride co-millings with MCC PH101, MCC KG802 and Cl-CMC-Na at 1∶3 ratio displayed a rapid-release characteristics. Conclusions co-millings of efondipine hydrochloride with clavate or threadiness excipients can produce a network like structure, which can not only effectively prevent the aggregation of micronized drug after co-milling but also improve the dissolution rate of efonidipine hydrochloride.
出处 《中国药剂学杂志(网络版)》 2015年第5期162-172,共11页 Chinese Journal of Pharmaceutics:Online Edition
关键词 药剂学 盐酸依福地平 共研磨 溶出机制 粉体学性质 pharmaceutics efonidipine hydrochloride co-milling dissolution mechanism powder property
  • 相关文献

参考文献6

  • 1Lauretta Maggi,Giovanna Bruni,Mariarosa Maietta,Andrea Canobbio,Andrea Cardini,Ubaldo Conte.II. Technological approaches to improve the dissolution behavior of nateglinide, a lipophilic insoluble drug: Co-milling[J]. International Journal of Pharmaceutics . 2013 被引量:1
  • 2Katharina Stank,Hartwig Steckel.Physico-chemical characterisation of surface modified particles for inhalation[J]. International Journal of Pharmaceutics . 2013 (1) 被引量:1
  • 3M.P. Vaidya,A.M. Avachat.Investigation of the impact of insoluble diluents on the compression and release properties of matrix based sustained release tablets[J]. Powder Technology . 2011 (3) 被引量:1
  • 4Tracy Tay,Ayman Allahham,David A.V. Morton,Peter J. Stewart.Counter-intuitive enhancement in the dissolution of indomethacin with the incorporation of cohesive poorly water-soluble inorganic salt additives[J]. European Journal of Pharmaceutics and Biopharmaceutics . 2011 (3) 被引量:1
  • 5Steve R. Marek,Martin J. Donovan,Hugh D.C. Smyth.Effects of mild processing pressures on the performance of dry powder inhaler formulations for inhalation therapy (1): Budesonide and lactose[J]. European Journal of Pharmaceutics and Biopharmaceutics . 2011 (1) 被引量:1
  • 6Shan-Yang Lin,Cheng-Hung Hsu,Wen-Ting Ke.Solid-state transformation of different gabapentin polymorphs upon milling and co-milling[J]. International Journal of Pharmaceutics . 2010 (1) 被引量:1

同被引文献11

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部